About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

About Market Research Forecast

U.S. Colorectal Cancer Screening Market

U.S. Colorectal Cancer Screening Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

U.S. Colorectal Cancer Screening Market by Type (Stool-based {Fecal Immunochemical Test (FIT), by End-user (Hospitals & Clinics, Clinical Laboratories, Diagnostic Imaging Centers, Others), by Forecast 2026-2034

Jan 19 2025

Base Year: 2025

180 Pages

U.S. Colorectal Cancer Screening Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

Key Insights

The U.S. Colorectal Cancer Screening Market size was valued at USD 10.38 USD Billion in 2023 and is projected to reach USD 14.13 USD Billion by 2032, exhibiting a CAGR of 4.5 % during the forecast period. Colon cancer screening utilizes different methods that are meant to detect not only the precancerous polyps but also the cancerous growths in the colon and rectum. Approaches like colonoscopy, sigmoidoscopy, FOBT (fecal occult blood tests), FIT (fecal immunochemical tests), and stool DNA tests are the methods of this section. Every type of screening has its own set of pros: it may be highly or low invasive, accurate, and/or performed very rarely or frequently. They tend to focus at the early stages, and preventive measures; in turn, they are very effective in reducing mortality rates. In the US market, current trends show consumers are now opting to use FIT and stool DNA tests mainly because the less-invasive tests are painless and deliver optimal results alongside improvements in technology which has resulted in tests that are accurate and affordable thus ensuring these tests are widely adopted and continue to improve patient outcomes.

U.S. Colorectal Cancer Screening Trends

Growing adoption of non-invasive screening methods
Increasing use of AI-powered screening tools
Rising focus on personalized screening approaches

Driving Forces:

U.S. Colorectal Cancer Screening Market Market Size and Forecast (2024-2030) — U.S. Colorectal Cancer Screening Market Company Market Share

Challenges and Restraints

Discomfort and invasiveness of traditional screening methods
Lack of awareness about screening guidelines
Cost of screening procedures

Emerging Trends

Point-of-Care Screening: Development of rapid and accurate point-of-care screening tests for increased accessibility.
Liquid Biopsy: Utilization of blood or saliva samples for colorectal cancer detection, offering non-invasive screening options.
Personalized Screening: Adoption of tailored screening strategies based on individual risk factors and genetic markers.

Growth Catalysts

Government Initiatives: Implementation of national screening programs and campaigns to increase public awareness and access to screening.
Reimbursement Coverage: Favorable reimbursement policies for screening procedures, making them more accessible to patients.
Research and Development: Ongoing research and development efforts to improve screening techniques and diagnostic tools.

Market Segmentation

Type:

Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT))
Colonoscopy
Sigmoidoscopy
Virtual Colonoscopy

End-user:

Hospitals & Clinics
Clinical Laboratories
Diagnostic Imaging Centers
Others

Leading Players

Exact Sciences Corporation (U.S.)
Epigenomics AG (Germany)
bioMérieux, Inc. (France)
Olympus Corporation (Japan)
KARL STORZ SE & Co. KG (Germany)
EIKEN CHEMICAL CO., LTD.
FUJIFILM Holdings America Corporation
Clinical Genomics Technologies Pty Ltd. (U.S.)

Comprehensive Coverage U.S. Colorectal Cancer Screening Market Report

Our updated report provides comprehensive insights into the U.S. colorectal cancer screening market, encompassing:

Market Size and Forecasts:
- Detailed analysis of the current market size and future growth projections, segmented by screening methods (e.g., colonoscopy, stool tests)
- Geographical segmentation by regions and submarkets
Trend and Driver Analysis:
- Identification and assessment of market trends, including technological breakthroughs (e.g., AI-assisted screening)
- Evaluation of regulatory changes and public health initiatives shaping market dynamics
Growth Opportunity Assessment:
- Exploration of emerging segments with high growth potential
- Analysis of innovative technologies and their impact on market growth
- Identification of untapped markets for expansion
Competitive Landscape Assessment:
- In-depth analysis of major market players and their market share
- Evaluation of product offerings, including screening devices and diagnostic tools
- Assessment of strategic initiatives, such as acquisitions and partnerships
SWOT Analysis:
- Comprehensive SWOT analysis of key market players, highlighting their strengths, weaknesses, opportunities, and threats
Company Profiles:
- Detailed profiles of leading companies, providing insights into:
Industry Developments:
- Tracking of industry events, such as mergers and acquisitions
- Reporting on product launches and regulatory updates
Regional Insights:
- Granular analysis of market dynamics and opportunities in key regions within the United States
- Geographic segmentation and growth projections for each region
- Identification of regional variations in screening practices and healthcare infrastructure

Import and Export Analysis

The report provides an in-depth analysis of the U.S.'s import and export activities related to colorectal cancer screening products and services.

Patent/Trademark Analysis

The report includes a detailed examination of the intellectual property landscape in the U.S. colorectal cancer screening market.

U.S. Colorectal Cancer Screening Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 4.5% from 2020-2034
Segmentation	By Type Stool-based {Fecal Immunochemical Test (FIT By End-user Hospitals & Clinics Clinical Laboratories Diagnostic Imaging Centers Others By Geography

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Introduction of Cost-effective Manufacturing Processes to Drive Market Growth
- - 3.3. Market Restrains
  - - 3.3.1. Adverse Effects Associated with the Use of Colonoscopes for Screening Limits the Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. U.S. Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
  - 5.1.1. Stool-based {Fecal Immunochemical Test (FIT
- 5.2. Market Analysis, Insights and Forecast - by End-user
  - 5.2.1. Hospitals & Clinics
  - 5.2.2. Clinical Laboratories
  - 5.2.3. Diagnostic Imaging Centers
  - 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - by Region
  - 5.3.1.
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 EIKEN CHEMICAL CO. LTD. (Japan)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Clinical Genomics Technologies Pty Ltd. (U.S.)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Exact Sciences Corporation (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Epigenomics AG (Germany)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 bioMérieux Inc. (France)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Olympus Corporation (Japan)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 KARL STORZ SE & Co. KG (Germany)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 FUJIFILM Holdings America Corporation (Japan)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)

List of Figures

Figure 1: U.S. Colorectal Cancer Screening Market Revenue Breakdown (USD Billion, %) by Product 2025 & 2033
Figure 2: U.S. Colorectal Cancer Screening Market Share (%) by Company 2025

List of Tables

Table 1: U.S. Colorectal Cancer Screening Market Revenue USD Billion Forecast, by Type 2020 & 2033
Table 2: U.S. Colorectal Cancer Screening Market Volume K Units Forecast, by Type 2020 & 2033
Table 3: U.S. Colorectal Cancer Screening Market Revenue USD Billion Forecast, by End-user 2020 & 2033
Table 4: U.S. Colorectal Cancer Screening Market Volume K Units Forecast, by End-user 2020 & 2033
Table 5: U.S. Colorectal Cancer Screening Market Revenue USD Billion Forecast, by Region 2020 & 2033
Table 6: U.S. Colorectal Cancer Screening Market Volume K Units Forecast, by Region 2020 & 2033
Table 7: U.S. Colorectal Cancer Screening Market Revenue USD Billion Forecast, by Type 2020 & 2033
Table 8: U.S. Colorectal Cancer Screening Market Volume K Units Forecast, by Type 2020 & 2033
Table 9: U.S. Colorectal Cancer Screening Market Revenue USD Billion Forecast, by End-user 2020 & 2033
Table 10: U.S. Colorectal Cancer Screening Market Volume K Units Forecast, by End-user 2020 & 2033
Table 11: U.S. Colorectal Cancer Screening Market Revenue USD Billion Forecast, by Country 2020 & 2033
Table 12: U.S. Colorectal Cancer Screening Market Volume K Units Forecast, by Country 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Colorectal Cancer Screening Market?

The projected CAGR is approximately 4.5%.

2. Which companies are prominent players in the U.S. Colorectal Cancer Screening Market?

Key companies in the market include EIKEN CHEMICAL CO., LTD. (Japan), Clinical Genomics Technologies Pty Ltd. (U.S.), Exact Sciences Corporation (U.S.), Epigenomics AG (Germany), bioMérieux, Inc. (France), Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), FUJIFILM Holdings America Corporation (Japan).

3. What are the main segments of the U.S. Colorectal Cancer Screening Market?

The market segments include Type, End-user.

4. Can you provide details about the market size?

The market size is estimated to be USD 10.38 USD Billion as of 2022.

5. What are some drivers contributing to market growth?

Introduction of Cost-effective Manufacturing Processes to Drive Market Growth.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Adverse Effects Associated with the Use of Colonoscopes for Screening Limits the Market Growth.

8. Can you provide examples of recent developments in the market?

April 2021 – Medtronic received the U.S. FDA approval for the GI Genius intelligent endoscopy module in the U.S. The GI Genius module was the first commercially available computer-aided detection (CADe) system that uses artificial intelligence (AI) to identify colorectal polyps.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD Billion and volume, measured in K Units.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "U.S. Colorectal Cancer Screening Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the U.S. Colorectal Cancer Screening Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the U.S. Colorectal Cancer Screening Market?

To stay informed about further developments, trends, and reports in the U.S. Colorectal Cancer Screening Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Colorectal Cancer Screening Market Report Probes the USD billion Size, Share, Growth Report and Future Analysis by 2033

Lung Cancer Screening Market Strategic Roadmap: Analysis and Forecasts 2025-2033

Liver Cancer Screening Market Analysis Report 2025: Market to Grow by a CAGR of 7.1 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Colorectal Cancer Therapeutics Market Future-proof Strategies: Trends, Competitor Dynamics, and Opportunities 2025-2033

Colorectal Cancer Screening Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report